WO2024252336 - PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF

National phase entry is expected:
Publication Number WO/2024/252336
Publication Date 12.12.2024
International Application No. PCT/IB2024/055561
International Filing Date 06.06.2024
Title [English] PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF [French] COMPOSITIONS PEPTIDIQUES CIBLANT LE GLYPICANE-3 ET LEURS UTILISATIONS
Applicants ** PEPTIDREAM INC. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
Inventors ** EHARA, Takeru c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP KOMURA, Rie c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP MIZUKOSHI, Yoshihide c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP MORIMOTO, Kouki c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP TAKUWA, Masatoshi c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP YANAGIDA, Hayato c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP OHUCHI, Masaki c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP NAGASAWA, Takayuki c/o PeptiDream Inc. 3-25-23 Tonomachi Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
Priority Data 63/506,651  07.06.2023  US
front page image
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 5310
EPO Filing, Examination 71411
Japan Filing 570
South Korea Filing 578
USA Filing, Examination 25835
+ Add country
MasterCard Visa
Total: 103704
QUOTE TO EMAIL ONLINE QUOTE
Abstract [English] The present technology generally relates to peptides that bind to phosphatidylinositol proteoglycan 3 (GPC3), to peptides that bind to the GPC3, and to compositions comprising such peptides. [French] La présente technologie concerne de manière générale des peptides qui se lient au phosphatidylinositol protéoglycane 3 (GPC3), des peptides qui se lient au GPC3, ainsi que des compositions comprenant de tels peptides.